Cargando…
Repurposing Lenvatinib as A Potential Therapeutic Agent against Thyroid Eye Disease by Suppressing Adipogenesis in Orbital Adipose Tissues
Thyroid eye disease (TED) is the most common orbital disease in adults. Targeting expanded orbital adipose tissue (OAT) removed by surgery has therapeutic potential. However, drugs targeting OAT are unavailable because of the lack of deciphering features of OAT. Here, we aimed to investigate the mec...
Autores principales: | Cheng, Lu, Hu, Jing, Zhang, Ling, Shen, Ning, Chen, Hui, Zhang, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696555/ https://www.ncbi.nlm.nih.gov/pubmed/36355477 http://dx.doi.org/10.3390/ph15111305 |
Ejemplares similares
-
Metabolic features of orbital adipose tissue in patients with thyroid eye disease
por: Du, Rui, et al.
Publicado: (2023) -
The Potential of Artemisinins as Novel Treatment for Thyroid Eye Disease by Inhibiting Adipogenesis in Orbital Fibroblasts
por: Guo, Yan, et al.
Publicado: (2023) -
Adipogenesis: It Is Not Just Lipid That Comprises Adipose Tissue
por: Dodson, Michael V., et al.
Publicado: (2013) -
Traumatic Orbital Floor Fracture Causing Therapeutic Orbital Decompression in Thyroid Eye Disease
por: Buoniconti, Patrick, et al.
Publicado: (2022) -
Changes of mRNA expression underlying orbital adipogenesis in thyroid-associated orbitopathy
por: Bai, Xiao Jing, et al.
Publicado: (2022)